The largest database of trusted experimental protocols

Plenti6.3 to v5 dest vector

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PLenti6.3/TO/V5-DEST vector is a lentiviral expression vector that allows for tetracycline-inducible gene expression in mammalian cells. The vector contains the V5 epitope tag and a Gateway® recombination cassette for easy cloning of genes of interest.

Automatically generated - may contain errors

5 protocols using plenti6.3 to v5 dest vector

1

Generation of Inducible PAX6, OCT4, KLF4 Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
We generated a ViraPowerTM T-RexTM OKF6/TERT-1 cell line through the transduction of pLenti3.3/TR (Life Technologies). The all-in-one cassettes were subcloned into a pLenti6.3/TO/V5-DEST vector (Life Technologies). After we transduced a ViraPowerTM T-RexTM OKF6/TERT-1 cell line with pLenti6.3/TO/V5-DEST vectors, we selected four PAX6-a/OCT4/KLF4- and PAX6-b/OCT4/KLF4-inducible colonies.
+ Open protocol
+ Expand
2

Tetracycline-Inducible OSM Expression in MDA-MB-231 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To transduce MDA-MB-231-Luc2-D3H2LN cells with a tetracycline (TET)-inducible vector, the full-length OSM complementary DNA was cloned into the pLenti6.3/TO/V5-DEST vector (Life Technologies). Lentiviral transduction of the pLenti6.3/TO/V5-DEST+hOSM vector and pLenti3.3/TR vector was performed using the ViraPower™ II Lentiviral Gateway® Expression System (K367-20; Life Technologies) in accordance with the manufacturer’s instructions. Stably transduced cell lines were tested for TET induction of hOSM expression by enzyme-linked immunosorbent assay (ELISA) and Western blot analysis. To create OSM-knockdown 4T1.2 cells, OSM short hairpin RNA (shRNA) and a LacZ shRNA sequences were cloned into the pSilencer 4.1 plasmid (Life Technologies) and stably transfected into 4T1.2 cells as previously described [7 (link)]. Two viable OSM-knockdown 4T1.2 cell lines were generated using different shRNA constructs (4T1.2-shOSM1 and 4T1.2-shOSM2) [7 (link)].
+ Open protocol
+ Expand
3

Lentiviral Vector Construction for let-7e Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus vectors expressing mature let-7e, anti-miRNA-oligo of let-7e (AMO-let-7e) or NC sequence were constructed by Invitrogen (Invitrogen). Briefly, the precursor sequence of let-7e and its antisense fragment were synthesized by Invitrogen. The synthesized fragments were annealed and inserted into the pcDNA™ 6.2-GW/EmGFP-miR vector (Invitrogen). Then, lentivirus plasmid was constructed by BP and LR recombination into pLenti6.3/TO/V5-DEST vector (Invitrogen) through the Gateway recombination technology. The constructed pLenti6.3/TO/V5-DEST plasmid and an optimized mix of the three packaging plasmid (pLP1, pLP2 and pLP/VSVG; Invitrogen, China) were cotransfected into 293FT procedure cell line by liposome reagent to package lentivirus. The virus liquid was collected and concentrated 48 hrs after cotransfection, and the titre of the lentivirus liquid was determined.
+ Open protocol
+ Expand
4

Conditional H-Ras Expression and DNA2 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pLenti6.3/TO/V5-H-Ras vector was obtained from Dr Shiaw-Yih Lin (Department of Systems Biology, MD Anderson Cancer Center). Briefly, PCMV-H-RAS (V12) was purchased from Invitrogen (Waltham, MA, USA) and subcloned into the pLenti6.3/TO/V5-DEST vector (Invitrogen) based on the commercial protocol of ViraPower TM HiPerform TM T-Rex TM Gateway Expression system (Thermo Fisher Scientific Waltham, MA, USA). pLenti3.3/TR and pLenti6.3/TO/V5-H-Ras were stably integrated into MCF10A cells. Expression of H-Ras was induced by the addition of doxycycline (1 μg/ml) for 48 h. The vector that expresses FLAG-tagged DNA2 has been described.33 (link) DNA2 short hairpin RNA vectors and control short hairpin RNA vectors against luciferase sequences were obtained from Sigma (St Louis, MO, USA; shDNA2#1: 5′-CCGGACCTGGTGTTGGCAGTCAATACTCGAGTATTGACTGCCAACACCAGGTTTTTTTG-3′; shDNA2#2: 5′-CCGGAGTTTGTGATGGGCAATATTTCTCGAGAAATATTGCCCATCACAAACTTTTTTTG-3′). On-target smart pool small interfering RNAs against DNA2 were purchased from Dharmacon Research (Lafayette, CO, USA; #9: 5′-AGACAAGGUUCCAGCGCCA-3′; #10: 5′-UAACAUUGAAGUCGUGAAA-3′ #11: 5′-AAGCACAGGUGUACCGAAA-3′; #12: 5′-GAGUCACAAUCGAAGGAUA-3′). Transfection of plasmids was performed with the FuGENE 6 reagent from Roche (Indianapolis, IN, USA). Transfection of small interfering RNAs was performed with Oligofectamine (Invitrogen).
+ Open protocol
+ Expand
5

Cloning and Lentiviral Transduction of FGFR1 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cDNAs encoding the full-length wild type FGFR1, as well as mutant FGFR1 p.N546K and FGFR1 p.R661P were purchased from OriGene (Rockville, MD, USA). The mutated and wild type FGFR1 cDNAs were amplified and cloned into a pCR8/GW/TOPO TA entry vector and subsequently sub-cloned into a pLenti6.3/TO/V5-DEST Vector (Invitrogen) using the Gateway LR Clonase II Enzyme mix (Invitrogen) according to the manufacturer's protocol. Clones were confirmed by bidirectional Sanger sequencing. HEK293T packaging cells were transfected with pLenti6.3/V5-TOPO plasmids containing wild type and mutants FGFR1, together with ViraPower packaging mix to produce a lentiviral stock. Supernatants were collected at 48, 60 and 72 h after transfection and viral particles were concentrated using PEG-it (System Biosciences). HEK293 cells were transduced with lentiviral particles and stable clones were selected with 10 μg/ml blasticidin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!